Search

Author/Creator Demir, Hacer

1. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. (9th August 2021)

Authors:
Bahçeci, Aykut; Paydaş, Semra; Ak, Naziye; Ferhatoğlu, Ferhat; Saip, Pınar Mualla; Seydaoğlu, Gülşah; Bilici, Mehmet; Şimşek, Melih; Tekin, Salim Başol; Çalikuşu, Züleyha; Yavuz, Sinan; Şahin, Ahmet Bilgehan; Çubukçu, Erdem; Evrensel, Türkkan; Değirmencioğlu, Serkan; Demiray, Atike Gökçen; Yumuk,...
Journal:
Cancer investigation
Issue:
Volume 39:Number 6/7(2021)
Page Start:
473
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Issue 7 (20th June 2022)

Authors:
Özdemir, Özlem; Zengel, Baha; Yildiz, Yaşar; Uluç, Basak Oyan; Cabuk, Devrim; Ozden, Ercan; Salim, Derya Kivrak; Paydas, Semra; Demir, Atakan; Diker, Omer; Pilanci, Kezban Nur; Sönmez, Özlem Uysal; Vatansever, Sezai; Dogan, Izzet; Gulmez, Ahmet; Cakar, Burcu; Gursoy, Pinar; Yildirim, Mahmut Emre;...
Journal:
Anti-cancer drugs
Issue:
Volume 33:Issue 7(2022)
Page Start:
663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search